Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-06

Clinical Trial Update: Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating esketamine combined with pregabalin for acute postoperative pain after resection of spinal neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esketamine (esketamine)
  • Pregabalin (Pregabalin)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Esketamine, Pregabalin | Phase 2, Phase 3 | Status: COMPLETED